OVID

Ovid Therapeutics Inc.

Company with tickers: OVID

Market Cap

$475.93M

Shares Outstanding

186,640,102

CIK

1636651

CUSIP

690469101

Website

Visit website

Investor Relations

Investor relations

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-04	Ovid Therapeutics to Participate in Upcoming Investor Conferences
2026-06-03	Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
2026-05-12	Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
2026-04-08	Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
2026-03-18	Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-18	Ovid Therapeutics Announces Pricing of $60 Million Private Placement
2026-02-25	Ovid Therapeutics to Participate in Upcoming Investor Conferences
2025-12-18	Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
2025-12-02	Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
2025-11-12	Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

Past events

Date	Event	Type
2026-06-15	H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference	Conference
2026-04-14	KCC2 Deep Dive R&D Event	Event
2026-03-18	Business and Pipeline Update Webcast	Webcast
2026-03-09	Leerink Global Healthcare Conference	Conference
2026-03-04	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-25	Oppenheimer 36th Annual Healthcare Life Sciences Conference	Conference
2025-10-03	OV329 topline results webcast from the phase 1 healthy volunteer study	Webcast
2025-06-12	Biomarkers in Epilepsy Investor Event	Event
2025-04-07	24th Annual Needham Virtual Healthcare Conference	Conference
2025-03-03	TD Cowen 45th Annual Health Care Conference	Conference
2025-02-12	Oppenheimer 35th Annual Healthcare Life Sciences Conference	Conference
2024-11-13	KCC2 Download Day	Event
2024-09-19	2024 Cantor Global Healthcare Conference	Conference
2024-09-10	H.C. Wainwright 26th Annual Global Investment Conference	Conference
2024-05-20	H.C. Wainwright 2nd Annual BioConnect Investor Conference	Conference
2024-04-11	23rd Annual Needham Virtual Healthcare Conference	Conference
2024-03-06	TD Cowen 44th Annual Health Care Conference	Conference
2024-02-13	Oppenheimer 34th Annual Healthcare Life Sciences Conference	Conference
2023-10-12	Jefferies Biotech CNS/Neuro Summit	Event
2023-10-02	Ovid R&D Day	Event
2023-09-26	2023 Cantor Fitzgerald Global Healthcare Conference	Conference
2023-09-12	H.C. Wainwright 25th Annual Global Investment Conference	Conference
2023-04-17	22nd Annual Needham Virtual Healthcare Conference	Conference
2023-03-15	2nd Annual Needham Virtual Neuroscience Forum	Event
2023-03-06	Cowen 43rd Annual Health Care Conference	Conference

Source: https://investors.ovidrx.com/overview/default.aspx